skip to main content

brainstorm askiatroX medicines

simulations beta

loading page…

learn & practise

exams international doctors free questions Socratic Tutor rounds stat clinical connections academy journal tool guides

clinical reference

askiatroX knowledge centre medicines UK / NICE guidance international guidance calculators q&a library

trust & support

how it works methodology account & support frequently asked questions about us clinical safety consultancy

legal

mobile app · scan to download

Medicines burosumabQuestion & answer

burosumab · Medicine question

Why are phosphate supplements stopped?

iatroX medicinesPublished 19 August 2026Reviewed 19 August 2026

The answer

Answer

Combining them with burosumab may raise phosphate and calcium excessively, increasing the risk of mineral deposits in tissues such as the kidneys.

Sources for this answer

CRYSVITA 10 mg solution for injection in pre-filled syringeemc · SmPC Current selected SmPC · Version 2
Crysvita solution for subcutaneous injectionemc · SmPC Current selected SmPC · Version 13

Explore this learning need in CPDTake this topic to CPD, then choose your learning context and available question library.

More questions about burosumab

Does burosumab treat every cause of low phosphate?Is burosumab suitable for children under 1 year?Can burosumab be self-injected at home?Can ordinary vitamin D be used?Why might kidney ultrasound be needed?Can burosumab affect driving?

The full medicine guide

burosumab

Read the wider context, including uses, precautions and the sources behind this medicine guide.

Read the burosumab guide

More clinical questions?

Explore the tools and reference material available on iatroX.

Explore askiatroX